Remdesivir, steroids, tocilizumab, favipiravir, and ivermectin are some of the drugs currently widely used to treat COVID19 infections. However, the timing of use of these medicines (based on the patient's condition) is important for their effectiveness. Recently, the Government of India has removed the off-label use of plasma therapy from COVID 19's recommended treatment guidelines, often because of its "ineffectiveness and inappropriate use". Experts have also reported that they are also considering removing remdesivir from COVID 19 treatment because there is no evidence of its effectiveness in treating patients. Remdesivir is given to patients with COVID 19 who are hospitalized and have a severe course of illness.
Meanwhile, the antibody-drug cocktail used to treat COVID 19 from Pharmaceutical giant Roche has received an emergency use authorization from the Central Drugs Standard Control Organization (CDSCO).
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
